Emmyon, Inc.

  • About Us
    • Overview
    • People
  • Technology
    • Platform
    • Natural Compounds
    • Novel Compounds
    • Patents
    • Publications
  • Commercial Applications
    • Human Nutrition
    • Companion Animal Nutrition
    • Production Animal Nutrition
    • Pharmaceuticals
  • News
  • Contact
Home / News / Emmyon scientists discover a novel molecular mechanism of skeletal muscle atrophy

Emmyon scientists discover a novel molecular mechanism of skeletal muscle atrophy

Jan 17, 2020 By redilson

January 17, 2020, Coralville, IA – In collaboration with colleagues at the University of Iowa and the Buck Institute for Research on Aging, Emmyon scientists Scott Ebert and Chris Adams published a new paper today describing a previously unknown mechanism of skeletal muscle atrophy.

The paper, entitled “Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBPβ” was published in the Journal of Biological Chemistry. To view the paper, please click here.

Filed Under: News

Emmyon logo
emmyon@emmyon.com LinkedIn logo
Emmyon® is a registed trademark of Emmyon, Inc.
© Copyright 2018 - 2025 Emmyon, Inc. All Rights Reserved.